Literature DB >> 31102047

CD146 expression in oral lichen planus and oral cancer.

Sarinthon Pariyawathee1, Ekarat Phattarataratip2, Kobkan Thongprasom3.   

Abstract

OBJECTIVE: To examine the CD146/METCAM expression on keratinocytes in normal oral mucosa (NOM), oral lichen planus (OLP), oral epithelial dysplasia (OED), and oral squamous cell carcinoma (OSCC). SUBJECTS AND METHODS: Immunohistochemical examination of CD146 was performed on 80 specimens, divided into 20 cases from each group. The number of CD146+ keratinocytes was quantitatively assessed together with the staining intensity.
RESULTS: The mean percentage of CD146+ keratinocytes was 19.04±15.32, 59.40±24.48, 60.04±28.87, and 22.13±21.03 in NOM, OLP, OED, and OSCC, respectively. The mean percentages of CD146+ keratinocytes in OLP and OED were significantly higher than those of NOM and OSCC (p≤0.001). Most OED (55%) and OLP (60%) showed strong and moderate staining intensity, respectively, while NOM (50%) and OSCC (45%) predominantly expressed CD146 at mild intensity.
CONCLUSIONS: This is the first study to examine CD146 expression in OLP and OED. CD146 is upregulated in OLP and OED but downregulated in OSCC. The alteration in CD146 may be involved in the immunoregulatory response of OLP and the early event of oral carcinogenesis. The loss of this protein may underlie the progression of OED into invasive OSCC. CLINICAL RELEVANCE: Overexpression of CD146 protein may play a role in the pathophysiology of OLP and OED.

Entities:  

Keywords:  CD146; METCAM; Oral epithelial dysplasia; Oral lichen planus; Oral squamous cell carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31102047     DOI: 10.1007/s00784-019-02871-7

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  22 in total

Review 1.  The role of CD146 (Mel-CAM) in biology and pathology.

Authors:  I M Shih
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

2.  Keratinocytes express the CD146 (Muc18/S-endo) antigen in tissue culture and during inflammatory skin diseases.

Authors:  W Weninger; M Rendl; M Mildner; C Mayer; J Ban; A Geusau; G Bayer; A Tanew; O Majdic; E Tschachler
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

Review 3.  Adhesion molecules as targets for cancer therapy.

Authors:  Y W Huang; R Baluna; E S Vitetta
Journal:  Histol Histopathol       Date:  1997-04       Impact factor: 2.303

4.  Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration.

Authors:  Nathalie Bardin; Valérie Moal; Francine Anfosso; Laurent Daniel; Philippe Brunet; José Sampol; Françoise Dignat George
Journal:  Thromb Haemost       Date:  2003-11       Impact factor: 5.249

Review 5.  Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146.

Authors:  Allal Ouhtit; Rajiv L Gaur; Zakaria Y Abd Elmageed; Augusta Fernando; Rajesh Thouta; Alison K Trappey; Mohamed E Abdraboh; Hassan I El-Sayyad; Prakash Rao; Madhwa G H Raj
Journal:  Biochim Biophys Acta       Date:  2009-01-29

6.  Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000.

Authors:  J M Lehmann; B Holzmann; E W Breitbart; P Schmiegelow; G Riethmüller; J P Johnson
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

Review 7.  CD146, a multi-functional molecule beyond adhesion.

Authors:  Zhaoqing Wang; Xiyun Yan
Journal:  Cancer Lett       Date:  2012-12-21       Impact factor: 8.679

8.  CD146 expression correlates with epithelial-mesenchymal transition markers and a poor prognosis in gastric cancer.

Authors:  Wen-Fang Liu; Shu-Rong Ji; Jian-Jun Sun; Yi Zhang; Zhong-Yan Liu; Ai-Bin Liang; Hua-Zong Zeng
Journal:  Int J Mol Sci       Date:  2012-05-23       Impact factor: 6.208

9.  Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.

Authors:  Dan Liu; Lei Du; Dong Chen; Zhongde Ye; Hongxia Duan; Tao Tu; Jing Feng; Yili Yang; Quan Chen; Xiyun Yan
Journal:  Oncotarget       Date:  2016-06-28

10.  Correlation of CD146 expression and clinicopathological characteristics in esophageal squamous cell carcinoma.

Authors:  Yan Li; Jin-Ming Yu; Xue-Mei Zhan; Li-Li Liu; Ning Jin; Yan-Xia Zhang
Journal:  Oncol Lett       Date:  2014-06-05       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.